Like any rapidly evolving industry, mobile health is suffering some growing pains.
A study published in the September issue of the journal Diabetes Care found that type 2 diabetes patients who were given behavioral coaching with the mobile phone-based WellDoc DiabetesManager system lowered their hemoglobin A1c readings significantly more than those who only received care during occasional doctor visits and through self-management.
If the WellDoc system was linked to clinical decision support, the results were striking. Researchers from the Department of Epidemiology and Public Health at the University of Maryland School of Medicine in Baltimore found that the group of patients whose physicians had access to CDS saw their A1c levels drop by 1.9 percentage points. Those in a control group, who only received traditional, office-based care had a median A1c reduction of 0.7 points.
“To our knowledge, this is the first cluster-randomized study of a mobile diabetes-coaching intervention conducted in a community setting over a 1-year treatment period. Few previous studies of electronic or mobile communication interventions for diabetes were randomized, included a control group or covered 1 year,” the researchers wrote.
But it was not all good news. The researchers observed no “convincing” changes in other measures of diabetes control, including blurred vision, pain, depression, and abnormal blood pressure and lipid counts. They hope future studies could focus more on these secondary measures of diabetes control, but for now, there remains plenty of fodder for skeptics in many areas of mobile health. Keep reading>>